Jorgen Engmann Selected Research

Gold

1/2016

Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorgen Engmann Research Topics

Disease

5	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 07/2014
5	Coronary Disease (Coronary Heart Disease) 10/2021 - 11/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2020
1	Cognitive Dysfunction 01/2023
1	Heart Diseases (Heart Disease) 12/2021
1	Stroke (Strokes) 10/2020
1	Heart Injuries 01/2020
1	ST Elevation Myocardial Infarction 01/2020
1	Myocardial Infarction 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Insulin Resistance 01/2019
1	Genetic Risk Score 10/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 12/2022 - 03/2015
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2015
2	LDL CholesterolIBA 12/2021 - 10/2020
1	KetonesIBA 01/2023
1	oxidized low density lipoproteinIBA 10/2020
1	Lipoproteins (Lipoprotein)IBA 10/2020
1	C-Reactive ProteinIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Troponin T (Troponin T1)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2016
1	Uric Acid (Urate)IBA 04/2016
1	GoldIBA 01/2016
1	HDL CholesterolIBA 03/2015
1	Apolipoproteins E (ApoE)IBA 11/2014
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 07/2014